Xiang Qi

Faculty

Xiang Qi headshot

Xiang Qi

PhD RN

Assistant Professor

1 212 992 5797

433 First Ave
New York, NY 10010
United States

Accepting PhD students

Xiang Qi's additional information

Xiang Qi, PhD, RN, is an Assistant Professor at the NYU Rory Meyers College of Nursing. A nurse-scientist with interdisciplinary training in gerontology and neurobiology, Prof. Qi’s research program operates at the critical intersection of geriatric oral health, social epidemiology & psychiatry, and dementia caregiving, with the goal of reducing disparities in Alzheimer’s disease and related dementias among older populations in the U.S. and globally. Qi is an expert in data science and advanced quantitative methods, including machine learning, multilevel modeling, and causal inference. He has extensive experience analyzing large-scale population health datasets and electronic health records to map the social determinants of health.

Qi is currently the principal investigator of an NIH-funded R01 project investigating the social and biological pathways linking poor oral health to dementia subtypes. His research challenges the historical separation of dental and medical care, providing robust evidence that oral health is a modifiable risk factor for Alzheimer’s disease and related dementias. His landmark research established a strong relationship between poor oral health and dementia risk, a finding that has reshaped clinical conversations around preventative oral care. Furthermore, his advocacy for including oral health in global dementia prevention guidelines was published in The Lancet.

In parallel, Qi is a leading voice in Asian American health research. He leads multiple NIH-funded studies (NIMHD P50, NIA P30) that utilize data disaggregation to reveal hidden disparities in cardiometabolic disease, mental health, and cognitive aging among diverse Asian American subgroups. Prior to his faculty appointment, Qi served as a postdoctoral research scientist at the Rutgers-NYU Center for Asian Health Promotion and Excellence, where he contributed to a community-based participatory intervention to support Chinese and Korean family caregivers of people with dementia.

His research has been featured by major media outlets such as CNN, U.S. News & World Report, Science News, and The Toronto Star. He serves on the Editorial Boards of Innovation in Aging and Discover Public Health. He has also held key roles within the Gerontological Society of America (GSA) Oral Health Interest Group, contributing to reports that advocate for expanded Medicare dental coverage. He further serves on advisory boards for community organizations like CaringKind and VNS Health, helping to bridge research with real-world improvements in dementia care.

PhD in Nursing Research and Theory Development, New York University
Exchange Program in Neurobiology, Physiology & Behavior, University of California, Davis
BS, Fudan University
Gerontology
Oral-systemic health
Public and Global Health
Underserved populations
Alzheimer’s Association International Society
New York Academy of Medicine
Sigma Theta Tau Nursing Honor Society
Gerontological Society of American
Eastern Nursing Research Society

Faculty Honors Awards

Research Poster Award, Health Equity Action Network (2024)
Minority Issues in Gerontology Student Poster Award, Gerontological Society of American (2023)
2022-2023 Outstanding PhD Dissertation Award, NYU Rory Meyers College of Nursing (2023)
The Emerging Scholar and Professional Organization – Best Poster Award, Gerontological Society of American (2022)
Minority Issues in Gerontology Student Poster Award, Gerontological Society of American (2022)
The Emerging Scholar and Professional Organization – Carol Schutz Student Travel Award, Gerontological Society of American (2022)
FIRE Doctoral Student Research Leadership Award, New York Academy of Medicine (2022)
Douglas Holmes Emerging Scholar Paper Award, Gerontological Society of American (2022)
Student Registration Award, Gerontological Society of American (2021)
Excellent Graduate of Shanghai, Shanghai Municipal Education Commission (2019)
National Undergraduate Scholarship, Ministry of Education of China (2018)
Research and Innovation Award, Fudan University, Fudan University, Shanghai, China (2018)
Overseas Exchange Outstanding Student Scholarship, Fudan University, China (2017)
The First Prize Scholarship, Fudan University, China (2016)
Excellent Student Leader, Fudan University, China (2015)

Publications

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

Failed generating bibliography.
Abstract
Abstract
For more than three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has provided a framework to quantify health loss due to diseases, injuries, and associated risk factors. This paper presents GBD 2023 findings on disease and injury burden and risk-attributable health loss, offering a global audit of the state of world health to inform public health priorities. This work captures the evolving landscape of health metrics across age groups, sexes, and locations, while reflecting on the remaining post-COVID-19 challenges to achieving our collective global health ambitions.

Concerns regarding prevalence estimates reported in the paper “Motoric cognitive risk syndrome and epigenetic aging”

Qi, X., & Qi, X. (2025). In Maturitas (Vols. 202).
Abstract
Abstract
~

Different Sources of Social Capital and Loneliness Among Adults in Shanghai, China: Exploring Sex Differences

Qi, X., Pei, Y., Li, G., Tang, W., Hall, B. J., & Wu, B. (2025). In Journal of Community & Applied Social Psychology. 10.1002/casp.70089
Abstract
Abstract
~

Edentulism, social mobility, and cognitive aging: a life course perspective

Qi, X., Liu, R., Luo, H., Qi, X., Xu, Z., & Wu, B. (2025). In The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences (Vols. 80, Issues 11, p. gbaf159).
Abstract
Abstract
~

Effects of choral singing on depression and anxiety in older adults : A randomized controlled trial

Ng, T. K., Lim, Z. H., Todd, M., Sun, F., Ray, K., Qi, X., Guo, J., Ye, K. X., Maier, A. B., Mahendran, R., Lee Gan, G., Tsakok, M., Kua, E. H., & Feng, L. (2025). In Journal of Psychiatric Research (Vols. 188, pp. 162-168). 10.1016/j.jpsychires.2025.05.061
Abstract
Abstract
Introduction: Few randomized controlled trials (RCTs) have investigated the effects of choral singing (CS) on older adults at-risk of cognitive decline and dementia. Extant RCTs on CS also lack an active control arm controlling for non-intervention-specific active components. Methods: In this parallel-arm, open-label RCT, 200 community-dwelling older adults at-risk of cognitive decline were randomized to the treatment arm, i.e., CS, or the active control arm (i.e., health education program, i.e., HEP, matched with non-intervention-specific components). Both arms involved weekly 1-h group sessions held continuously for two years. We examined the a priori registered secondary outcomes, positive screens for depressive and anxiety disorders, at baseline, 1-year, and 2-year time-points, using linear-mixed models with intention-to-treat. Results: Compared to the HEP, CS participants experienced similar decreased odds of positive screens for depressive and anxiety disorders throughout all the time-points, though different trajectories. Discussion: In contrary to previous studies using passive controls reporting positive outcomes, compared to HEP as an active comparator, CS is as effective as HEP in delaying progression to clinically significant depressive and anxiety disorders in at-risk community-dwelling older adults. Our findings highlight the critical importance of incorporating an intervention-components-matched comparison arm in non-pharmacological interventions. Trial registration: Choral Singing For the Prevention of Dementia, https://clinicaltrials.gov/study/NCT02919748; Trial Registration: NCT02919748.

Efficacy of a culturally tailored intervention on perceived stigma among women living with HIV/AIDS in China : A randomized clinical trial

Yang, Z., Han, S., Qi, X., Wang, J., Xu, Z., Mao, W., Zheng, Y., Zhang, Y., Wu, B., & Hu, Y. (2025). In Ethics in Science and Medicine (Vols. 374, p. 118072). 10.1016/j.socscimed.2025.118072
Abstract
Abstract
BACKGROUND: Despite evidence supporting the efficacy of culturally tailored interventions in reducing stigma, such approaches are lacking for women living with HIV/AIDS (WLWHAs) in China. We conducted this study to determine the efficacy of the culturally tailored Helping Overcome Perceived Stigma (HOPES) intervention in reducing perceived stigma among WLWHAs in China.METHODS: A single-blinded, two-arm parallel-group randomized clinical trial was conducted from 2023 to 2024 in South and Southwest China. WLWHAs from four hospitals were assigned using a WeChat-embedded randomization application to the control group (usual care) or the HOPES intervention. Data analysts remained blinded. Interventions were conducted virtually using Leave No One Behind (LNOB) platform for 3 months. The primary outcome, perceived stigma score, was assessed at baseline, immediately after the intervention and at 3 months post-intervention using 7 items from the HIV/AIDS Stigma Experience Questionnaire (HASEQ), with data analyzed through repeated measures analysis.RESULTS: Of 136 WLWHAs screened, we randomized 101 WLWHAs (50 HOPES; 51 controls). The HOPES group demonstrated a statistically significant reduction in perceived stigma scores immediately after the intervention (-3.86 points, 95 % CI: 5.34 to -2.38, P < .001) and at three months post-intervention (-5.83 points, 95 % CI: 7.20 to -4.47, P < .001) compared to the control group.CONCLUSION: The findings demonstrate HOPES' efficacy in reducing perceived stigma in WLWHA. However, the clinical significance of these changes needs further investigation. Future research should focus on defining meaningful patient-reported thresholds, assessing long-term impact, and optimizing delivery methods.

Engaging Chinese and Korean American communities in dementia research: A journey of inclusivity and partnership

Qi, X., Wang, J., Qi, X., Mittelman, M. S., Ko, E., Pei, Y., Leong, I. T. T., Park, S., Wang, K., Mao, W., Epstein, C., & Wu, B. (2025). In Alzheimer’s &amp; dementia : the journal of the Alzheimer’s Association (Vols. 21, Issues 10, p. e70664).
Abstract
Abstract
The New York University Caregiver Intervention plus Enhanced Support Project is a randomized controlled trial of a family-based psychosocial intervention to enhance social support and reduce cardiometabolic risk for Chinese and Korean American dementia caregivers, using culturally tailored recruitment strategies.

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

Failed generating bibliography.
Abstract
Abstract
Timely and comprehensive analyses of causes of death stratified by age, sex, and location are essential for shaping effective health policies aimed at reducing global mortality. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 provides cause-specific mortality estimates measured in counts, rates, and years of life lost (YLLs). GBD 2023 aimed to enhance our understanding of the relationship between age and cause of death by quantifying the probability of dying before age 70 years (70q0) and the mean age at death by cause and sex. This study enables comparisons of the impact of causes of death over time, offering a deeper understanding of how these causes affect global populations.

Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

Failed generating bibliography.
Abstract
Abstract
Lower respiratory infections (LRIs) remain the world's leading infectious cause of death. This analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 provides global, regional, and national estimates of LRI incidence, mortality, and disability-adjusted life-years (DALYs), with attribution to 26 pathogens, including 11 newly modelled pathogens, across 204 countries and territories from 1990 to 2023. With new data and revised modelling techniques, these estimates serve as an update and expansion to GBD 2021. Through these estimates, we also aimed to assess progress towards the 2025 Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea (GAPPD) target for pneumonia mortality in children younger than 5 years.

Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023

Qi, X., Diseases, G. B., & Collaborators, R. 2023. (2025). In Journal of the American College of Cardiology (Vols. 86, Issues 22, p. 2167-2243).
Abstract
Abstract
~

Media